These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27685608)

  • 21. Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria.
    Asero R
    Eur Ann Allergy Clin Immunol; 2018 Sep; 50(5):226-228. PubMed ID: 29384107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
    Chen JR; Buchmiller BL; Khan DA
    J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
    Ledford DK; Lockey RF
    J Allergy Clin Immunol Pract; 2016; 4(4):590-8. PubMed ID: 27393773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent coxibs and anti-platelet therapy unmasks aspirin-exacerbated respiratory disease.
    Bobolea I; Cabañas R; Jurado-Palomo J; Fiandor A; Quirce S
    Eur Respir J; 2013 Nov; 42(5):1418-20. PubMed ID: 24178936
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE; White A; Simon RA; Stevenson DD
    Allergy Asthma Proc; 2012; 33(2):117-21. PubMed ID: 22525387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria.
    Cavkaytar O; Arik Yilmaz E; Buyuktiryaki B; Sekerel BE; Sackesen C; Soyer OU
    Allergy; 2015 Feb; 70(2):153-60. PubMed ID: 25353369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD).
    Priyadharshini VS; Jiménez-Chobillon MA; de Graaf J; Porras Gutiérrez de Velasco R; Gratziou C; Ramírez-Jiménez F; Teran LM
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
    Mastalerz L; Sanak M; Gawlewicz A; Gielicz A; Faber J; Szczeklik A
    J Allergy Clin Immunol; 2006 Oct; 118(4):957-8. PubMed ID: 17030252
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma.
    Karakaya G; Celebioglu E; Kalyoncu AF
    Respir Med; 2013 Jul; 107(7):967-74. PubMed ID: 23643317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab can inhibit respiratory reaction during aspirin desensitization.
    Lang DM; Aronica MA; Maierson ES; Wang XF; Vasas DC; Hazen SL
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):98-104. PubMed ID: 29777744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Surgery in Management of Samter's Triad: A Systematic Review.
    Adelman J; McLean C; Shaigany K; Krouse JH
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):220-37. PubMed ID: 27071444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
    Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
    Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial.
    Sánchez J; García E; Lopez JF; Calle A; Buendia JA
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2172-2179. PubMed ID: 37146885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.